0.2% Dexamethasone Sodium Phosphate ịgba ọgwụ
.png)
.png)
.png)
.png)
Pharmacological omume
Mmetụta nke dexamethasone bụ isi iyi nke hydrocortisone, ma mmetụta ya dị ogologo, oge dị irè dị ogologo, na mmetụta ndị dị ntakịrị.Mmetụta nke gluconeogenesis na gluconeogenesis bụ ugboro 25 nke hydrocortisone, ebe mmetụta nke njigide sodium na mkpochapụ potassium dị ntakịrị karịa nke hydrocortisone.Mgbochi nke pituitary-adrenocortical axis.Na mgbakwunye na mmetụta ndị a dị n'elu, a pụkwara iji ngwaahịa a maka ntinye ọrụ n'ime mmiri mmiri ndị a na-enye n'otu oge, ma ọ nwere ike ịbawanye ọnụego nke placenta, na-egbu oge ịmụ nwa, ma weghachite akpanwa na ọnọdụ nkịtị n'oge.
Intramuscular injection gosiri a ngwa ngwa usoro mmetụta na nkịta, na ọnụ ọgụgụ kasị elu ọbara mkpokọta na 0.5 awa na ọkara ndụ nke ihe dị ka awa 48, tumadi excreted na feces na mmamịrị.
Ngosipụta
0.2% ogwu ogwu DexamethasonA na-eji maka ọrịa na-efe efe siri ike, dị ka sepsis dị iche iche, oyi baa na-egbu egbu, ọnyụnyụ bacillary na-egbu egbu, peritonitis, na ngwa ngwa mgbe ọmụmụ nwa.
ọgwụgwọ adjuvant maka metritis mmekọahụ;ọgwụgwọ nke ọrịa nfụkasị ahụ, dị ka nfụkasị rhinitis, urticaria, nfụkasị iku ume mbufụt, nnukwu ụkwụ-na-akwukwo mbufụt, nfụkasị eczema, wdg;ọgwụgwọ ujo kpatara ihe dị iche iche;ketonemia na ovine toxemia nke afọ ime, wdg;na ntinye nke nnyefe n'otu oge na ehi na atụrụ.
Usoro onunu ogwu na nchịkwa
Intramuscular na igba ogwu ogbugba: kwa ụbọchị dose, 1:25 ~ 2:5ml maka ịnyịnya;2:5 ~ 10ml maka ehi;2 ~ 6ml maka atụrụ na ezi;0:0625 ~ 0:5ml maka nkịta na nwamba.Intra-articular injection: 1 ~ 5ml maka inyinya na ehi.
Mmetụta ọjọọ
(1) sodium siri ike na njide mmiri na mkpochapụ potassium.
(2) Ọ nwere mmetụta immunosuppressive siri ike.
(3) Nnukwu doses n'ime ime afọ ime nwere ike ime ka ite ime.
(4) Ọ nwere ike iduga dulling, nkụchi ntutu, ibu ibu, swings, vomiting, afọ ọsịsa, elu imeju ọgwụ-metabolizing enzymes, pancreatitis, eriri afọ ọnya, lipemia, ịkpalite ma ọ bụ na-akawanye njọ ọrịa shuga, muscle atrophy, na mgbanwe omume (nda mbà n'obi, lethargy). , na mbuso agha) na nkịta, nke nwere ike ịchọ ka ịkwụsị ọgwụ ahụ.
(5) Mgbe ụfọdụ, a na-ahụ polydipsia, polyphagia, polyuria, uru arọ, afọ ọsịsa, ma ọ bụ ịda mbà n'obi na nwamba.Ọgwụgwọ ogologo oge na oke doses nwere ike ibute ọrịa Cushingoid.
Mkpachapụ anya
(1) Ghọta nke ọma ihe ndị na-egosi iji gbochie mmegbu.
(2)Ekwesịrị iji ya na ọgwụ nje maka nje nje.
(3) Ọ bụ contraindicated na ụmụ anụmanụ na oké ogbenye imeju ọrụ, osteochondrosis, mgbaji ọgwụgwọ oge, ọnya mmezi oge na ịgba ọgwụ mgbochi ọrịa oge.
(4) Ọ bụ contraindicated na dams na mmalite na mbubreyo ime.
(5) Enweghị ike ịkwụsị iji ogologo oge eme ihe na mberede na a ga-akụ ya ruo mgbe a kwụsịrị.
Oge mwepụ
Ụbọchị 21 maka ehi, atụrụ na ezi n'oge ezumike;72 awa maka oge agbahapụ.
Nchekwa
Na-echekwa n'ime ihe ndị a kpuchiri ekpuchi, na-echebe site na ìhè.
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.
